SCOR SE ADR
SCRYY: PINX (USA)
Morningstar Rating for Stocks | Fair Value | Economic Moat | Capital Allocation |
---|---|---|---|
$8.10 | Lfj | Rzfddbjb |
Scor Updates on Life and Health Reserving Review; Shares Undervalued
Following the negative life and health experience variance Scor incurred in the first quarter as a result of elevated levels of US mortality, Scor has issued an update for its second-quarter results for 2024. During the first quarter Scor outlined it would monitor the situation and once enough information had been gathered make a decision on the adequacy of reserves. Scor now has enough information to make a decision and has decided to accelerate its annual life and health reserve assumptions review.